A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
Rain in the southwest of England will gradually spread further north and east.
A four-year-old boy has died after being hit by a car outside a medical centre in Leeds.
The McCanns said they will do "whatever it takes for as long as it takes" to find their daughter, ten years after her disappearance.